VisionWave Registers $50M Equity Line with YA II, Bolstering Liquidity

TL;DR

**VWAVW just locked in a $50M equity line with YA II, signaling a cash injection but brace for potential dilution as shares hit the market at a discount.**

AI Summary

VisionWave Holdings, Inc. (VWAVW) filed an S-1/A on November 12, 2025, to register the resale of up to 10,200,000 shares of common stock, including 10,000,000 shares issuable to YA II PN, LTD. under a Standby Equity Purchase Agreement (SEPA) and 200,000 commitment shares. The SEPA allows VisionWave to sell up to $50 million of common stock to YA II at 97% of the lowest daily VWAP during a three-day period, with a minimum acceptable price. YA II also provided a $5.0 million Pre-Paid Advance in convertible promissory notes, with $3.0 million disbursed on July 25, 2025, and the remaining $2.0 million contingent on the registration statement's effectiveness. These notes accrue interest at 6.0% annually, increasing to 18% upon default, and are convertible at the lower of $10.00 or 93% of the lowest daily VWAP over five days, with a floor price of $1.00. VisionWave paid YA II a $35,000 structuring fee and 200,000 shares as an equity fee, plus a $500,000 commitment fee payable in shares. The company's common stock traded at $11.72 per share on November 10, 2025, on Nasdaq.

Why It Matters

This S-1/A filing is crucial for VisionWave Holdings as it outlines a significant financing mechanism, the Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., providing access to up to $50 million in capital. For investors, this means potential dilution from the issuance of up to 10,200,000 shares, but also a clearer path to funding operations and growth, potentially reducing immediate bankruptcy risk. Employees and customers benefit from the increased financial stability, which supports ongoing business development and service delivery. In a competitive market, securing this flexible funding source could give VisionWave an edge by enabling strategic investments or weathering market downturns, although the terms of the SEPA, particularly the discounted share sales, could pressure the stock price.

Risk Assessment

Risk Level: high — The risk level is high due to significant potential dilution and market price pressure. The company can sell up to 10,000,000 shares to YA II at 97% of the lowest daily VWAP, and YA II can convert $5.0 million in notes at 93% of the lowest daily VWAP, with a $1.00 floor. This continuous selling pressure from YA II, acting as an 'underwriter,' could depress the stock price, especially given the 4.99% ownership limitation which encourages frequent, smaller sales.

Analyst Insight

Investors should closely monitor VWAVW's daily trading volume and VWAP for signs of YA II's selling activity, as continuous sales could create downward pressure on the stock price. Consider the potential for significant dilution from the 10,200,000 registered shares and the $5.0 million in convertible notes when evaluating future share value.

Financial Highlights

debt To Equity

Not Disclosed

revenue

Not Disclosed

operating Margin

Not Disclosed

total Assets

Not Disclosed

total Debt

Not Disclosed

net Income

Not Disclosed

eps

Not Disclosed

gross Margin

Not Disclosed

cash Position

Not Disclosed

revenue Growth

Not Disclosed

Key Numbers

• 10,200,000 Shares — Common Stock Registered for Resale (Includes 10,000,000 shares for SEPA and 200,000 commitment shares.)
• $50,000,000 — Maximum Equity Sales under SEPA (Amount VisionWave can sell to YA II over 24 months.)
• 97% — Purchase Price Discount for SEPA Advances (YA II purchases shares at 97% of the lowest daily VWAP.)
• $5,000,000 — Pre-Paid Advance in Convertible Notes (Aggregate principal amount from YA II, with $3.0M already disbursed.)
• 6.0% — Annual Interest Rate on Convertible Notes (Increases to 18% upon an event of default.)
• $1.00 — Floor Price for Convertible Note Conversion (Minimum conversion price for YA II's convertible notes.)
• $11.72 — Common Stock Price on Nov 10, 2025 (Last reported sale price on Nasdaq.)
• $35,000 — Structuring Fee Paid to YA II (Paid as consideration for YA II's commitment.)
• 200,000 Shares — Equity Fee Paid to YA II (Shares issued as consideration for YA II's commitment.)
• $500,000 — Commitment Fee to YA II (Payable in common shares in two installments.)

Key Players & Entities

• VisionWave Holdings, Inc. (company) — Registrant and issuer of common stock
• YA II PN, LTD. (company) — Selling Stockholder and Investor in SEPA
• Douglas Davis (person) — Executive Chairman of VisionWave Holdings, Inc.
• Stephen M. Fleming, Esq. (person) — Legal counsel from Fleming PLLC
• Securities and Exchange Commission (regulator) — Regulatory body for S-1/A filing
• Nasdaq Stock Market (company) — Exchange where VWAVW common stock is traded
• Bloomberg L.P. (company) — Source for VWAP reporting
• Delaware (company) — State of incorporation for VisionWave Holdings, Inc.
• 300 Delaware Avenue, Suite 210 #301, Wilmington, Delaware 19801 (company) — Principal executive offices of VisionWave Holdings, Inc.
• 1063 N Spaulding Ave., West Hollywood, CA 90046 (company) — Operating office of VisionWave Holdings, Inc.

FAQ

Risk Factors

• Reliance on Standby Equity Purchase Agreement [high — financial]: The company's ability to raise capital is heavily reliant on the SEPA with YA II PN, LTD. This agreement allows VisionWave to sell up to $50 million of common stock at a discount (97% of VWAP), which could lead to significant dilution for existing shareholders. The effectiveness of the registration statement is critical for accessing these funds.
• Convertible Note Obligations [high — financial]: VisionWave has issued $5.0 million in convertible promissory notes to YA II. These notes accrue 6.0% interest, increasing to 18% upon default. The conversion price is tied to VWAP with a floor of $1.00, meaning conversion could occur at a significant discount to current market prices, further diluting shareholders.
• Stock Price Volatility and VWAP Dependence [medium — market]: The SEPA and convertible notes are directly tied to the company's stock price (VWAP). Fluctuations in the stock price, which traded at $11.72 on November 10, 2025, can significantly impact the effective price at which VisionWave can issue shares or convert debt, creating uncertainty in capital raising.
• Dependence on YA II PN, LTD. [high — operational]: The company's financial strategy is heavily dependent on YA II PN, LTD. for both equity and debt financing. This concentration of counterparty risk means that any issues with YA II could severely impact VisionWave's ability to operate and fund its growth.
• Dilution from Equity and Debt Instruments [high — financial]: The SEPA allows for the issuance of up to 10,000,000 shares to YA II, and the convertible notes can also be converted into shares. Combined with the 200,000 commitment shares and potential additional shares for commitment fees, the total potential dilution is substantial, impacting earnings per share and shareholder value.

Industry Context

VisionWave Holdings operates in a sector that often relies on external financing to fuel growth, particularly for early-stage or rapidly expanding companies. The competitive landscape likely involves numerous players vying for market share and investor capital. Trends may include technological innovation, evolving consumer demand, and increasing regulatory scrutiny.

Regulatory Implications

The S-1/A filing indicates VisionWave is seeking to register shares for resale, which is subject to SEC oversight. Compliance with securities laws and regulations is paramount. The SEPA and convertible note structures, while common, carry risks of dilution and potential regulatory challenges if not structured and disclosed properly.

What Investors Should Do

1. Monitor SEPA Utilization and Dilution
2. Analyze Convertible Note Conversion Terms
3. Assess YA II PN, LTD. Relationship
4. Review Future Filings for Financial Performance

Key Dates

• 2025-11-12: Filing of S-1/A Registration Statement — Initiates the process for registering the resale of up to 10,200,000 shares, crucial for accessing capital via the SEPA and potentially converting debt.
• 2025-11-10: Common Stock Last Traded Price — Reported at $11.72 on Nasdaq, this price serves as a benchmark for current valuation and influences SEPA and convertible note conversion terms.
• 2025-07-25: Disbursement of Pre-Paid Advance — $3.0 million of the $5.0 million convertible note advance was disbursed, indicating initial funding and the start of interest accrual.

Glossary

Standby Equity Purchase Agreement (SEPA)

An agreement where an investor commits to purchase shares of a company's stock upon the company's request, typically over a period of time and up to a certain amount, often at a discount to market price. (VisionWave can sell up to $50 million of stock to YA II PN, LTD. under this agreement, providing a flexible but dilutive source of capital.)

Volume Weighted Average Price (VWAP)

The average price of a security over a given period, weighted by the volume of trades at each price level. It's often used as a benchmark for trading execution. (The SEPA purchase price and convertible note conversion price are based on VWAP, making stock price movements and trading volume critical.)

Convertible Promissory Note

A debt instrument that can be converted into equity (shares of common stock) under certain conditions, such as a specified conversion price or trigger events. (YA II PN, LTD. provided $5.0 million in these notes, which can be converted into VisionWave stock, potentially diluting existing shareholders.)

Registration Statement

A filing with the SEC that allows a company to sell securities to the public. An S-1/A is an amendment to an initial S-1 filing. (The effectiveness of VisionWave's S-1/A is a prerequisite for the resale of shares under the SEPA and for the conversion of the convertible notes.)

Commitment Shares

Shares issued by a company to an investor as part of an agreement, often as consideration for the investor's commitment to provide future funding or services. (VisionWave issued 200,000 commitment shares to YA II PN, LTD. as part of their financing arrangement.)

Year-Over-Year Comparison

This S-1/A filing focuses on the registration of shares for resale related to financing agreements, specifically the Standby Equity Purchase Agreement (SEPA) and convertible notes with YA II PN, LTD. It does not provide comparative financial data against a prior period filing. Key metrics such as revenue, net income, and margins are not detailed in this document, making a direct comparison of operational performance impossible at this stage. The primary focus is on the structure and terms of the capital raising activities.

Key Financial Figures

• $0.01 — 0 shares of our common stock, par value $0.01 per share (“common stock”),
• $50 million — ny has the right to sell to YA II up to $50 million of its shares of common stock, subject
• $5.0 million — dquo;) an aggregate principal amount of $5.0 million (the “Pre-Paid Advance”). T
• $3.0 million — bursed on July 25, 2025 with respect to $3.0 million and the balance of $2.0 million will be
• $2.0 million — pect to $3.0 million and the balance of $2.0 million will be disbursed upon the registration
• $10.00 — conversion price equal to the lower of $10.00 or 93% of the lowest daily VWAP during
• $1.00 — may the Conversion Price be lower than $1.00 (the “Floor Price”). In add
• $750,000 — and continuing monthly in the amount of $750,000 plus a 5.0% premium and all accrued and
• $50,000,000 — EPA for shares of common stock equal to $50,000,000. We have the right to terminate the SEP
• $35,000 — (i) a structuring fee in the amount of $35,000 and (ii) 200,000 shares of common stock
• $500,000 — quired to pay YA II a commitment fee of $500,000 of which $250,000 shall be due and paya
• $250,000 — I a commitment fee of $500,000 of which $250,000 shall be due and payable on the earlier
• $11.72 — price on Nasdaq of our common stock was $11.72 per share. Our principal executive off

Filing Documents

• e7024_s-1a.htm (S-1/A) — 2776KB
• e7024_ex23-1.htm (EX-23.1) — 4KB
• e7024_ex23-2.htm (EX-23.2) — 4KB
• e7024_ex23-3.htm (EX-23.3) — 4KB
• 0001731122-25-001521.txt ( ) — 2790KB

Risk Factors

Risk Factors 8 Dividend Policy 21 Market for our Common Stock 21 Management’s Discussion and Analysis of Financial Condition and Results of Operations 22

Business

Business 31 Management 40

Executive Compensation

Executive Compensation 45

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 52 Selling Stockholders 53

Description of Securities

Description of Securities 55 Certain Relationships and Related Party Transactions 61 Legal Matters 65 Experts 65 Where You Can Find More Information 65 Index to Financial Statements F-1 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the “SEC”) using the “shelf” registration process. Under this shelf registration process, the Selling Stockholders may, from time to time, sell the securities offered by it described in this prospectus. We will not receive any proceeds from the sale by such Selling Stockholder of the securities offered by it described in this prospectus. Neither we nor the Selling Stockholder have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Stockholder take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. Neither we nor the Selling Stockholder will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the section of this prospectus entitled “ Where You Can Find More Information .” Unless the context indicates otherwise, references in this prospectus to the “Company,” “VisionWave Holdings,” “VisionWave,” “we,

View Full Filing

View this S-1/A filing on SEC EDGAR